menu
    • menu

    Company profile for Regulus Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Regulus was formed in September 2007 by Alnylam Pharmaceuticals (NASDAQ:ALNY) and Isis Pharmaceuticals, now Ionis Pharmaceuticals and has continued to build upon its thought leadership, knowledge base and intellectual property. Together the Regulus team is focused on the discovery and development of microRNA therapeutics. Regulus Therapeutics is located in La Jolla, California and is led by a seasoned executive team and board ...
    Regulus was formed in September 2007 by Alnylam Pharmaceuticals (NASDAQ:ALNY) and Isis Pharmaceuticals, now Ionis Pharmaceuticals and has continued to build upon its thought leadership, knowledge base and intellectual property. Together the Regulus team is focused on the discovery and development of microRNA therapeutics. Regulus Therapeutics is located in La Jolla, California and is led by a seasoned executive team and board of directors, with proven expertise in corporate management, business operations, drug discovery and development. Regulus’ scientific advisors consist of world-class scientists and several of the foremost authorities.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Regulus TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    10614 Science Center Dr. San Diego, CA 92121
    Telephone
    Telephone
    1-888-REGULUS (734-8587)
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.regulusrx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/regulus-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/search?q=Regulus%20Therapeutics&src=typd

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Novartis completes acquisition of Regulus Therapeutics
    Novartis completes acquisition of Regulus Therapeutics

    25 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/25/3105176/0/en/Novartis-completes-acquisition-of-Regulus-Therapeutics.html

    GLOBENEWSWIRE
    25 Jun 2025
    Share Share
    Novartis starts tender offer for Regulus Therapeutics
    Novartis starts tender offer for Regulus Therapeutics

    27 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/27/3088519/0/en/Novartis-announces-commencement-of-tender-offer-to-acquire-Regulus-Therapeutics.html

    GLOBENEWSWIRE
    27 May 2025
    Share Share
    Regulus Therapeutics Reports Q1 2025 Financial Results
    Regulus Therapeutics Reports Q1 2025 Financial Results

    08 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/regulus-therapeutics-reports-first-quarter-2025-financial-results-and-recent-updates-302449287.html

    PR NEWSWIRE
    08 May 2025
    Share Share
    Novartis to buy Regulus in up to $1.7 Billion deal
    Novartis to buy Regulus in up to $1.7 Billion deal

    01 May 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-buy-regulus-therapeutics-up-17-billion-2025-04-30/

    REUTERS
    01 May 2025
    Share Share
    Regulus Therapeutics Completes Phase 1b Trial of RGLS8429 for ADPk
    Regulus Therapeutics Completes Phase 1b Trial of RGLS8429 for ADPk

    27 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/regulus-therapeutics-announces-successful-completion-of-its-phase-1b-multiple-ascending-dose-mad-clinical-trial-of-farabursen-rgls8429-for-the-treatment-of-autosomal-dominant-polycystic-kidney-disease-adpkd-302412705.html

    PR NEWSWIRE
    27 Mar 2025
    Share Share
    Regulus Therapeutics Reports 2024 Financial Results and Updates
    Regulus Therapeutics Reports 2024 Financial Results and Updates

    13 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/regulus-therapeutics-reports-fourth-quarter-and-year-end-2024-financial-results-and-recent-updates-302401099.html

    PR NEWSWIRE
    13 Mar 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search